MedPath

HYDRA LONGEVITY OPERATIONS PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

TGA:3

Drug Approvals

Hydra Longevity Stress-FX (444898)

Product Name
Hydra Longevity Stress-FX
Approval Date
Mar 28, 2024
TGA

Hydra Longevity Cellular Energy (444673)

Product Name
Hydra Longevity Cellular Energy
Approval Date
Mar 27, 2024
TGA

Hydra Longevity Liver-FX (441820)

Product Name
Hydra Longevity Liver-FX
Approval Date
Feb 21, 2024
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.